Ionis Pharmaceuticals (IONS) Treasury Shares (2012 - 2025)

Ionis Pharmaceuticals' Treasury Shares history runs 14 years deep, the most recent figure standing at $4.7 million for Q4 2025.

• On a quarterly basis, Treasury Shares rose 23.83% year-over-year to $4.7 million in Q4 2025; TTM through Dec 2025 was $4.7 million, a 23.83% increase from a year earlier, with the FY2025 full-year figure at $4.7 million, up 23.83% from the prior year.
• Treasury Shares grew to $4.7 million in Q4 2025 per IONS's latest filing, from $3.8 million in the prior quarter.
• Across five years, Treasury Shares topped out at $4.7 million in Q4 2025 and bottomed at $59000.0 in Q4 2021.
• The 5-year median for Treasury Shares is $3.2 million (2023), against an average of $2.9 million.
• Across the five-year window, Treasury Shares plunged 97.51% in 2021 and jumped 4588.14% in 2022, its largest moves.
• Year by year, Treasury Shares stood at $59000.0 in 2021, then soared by 4588.14% to $2.8 million in 2022, then grew by 17.1% to $3.2 million in 2023, then climbed by 18.28% to $3.8 million in 2024, then grew by 23.83% to $4.7 million in 2025.
• Per Business Quant, the three latest IONS Treasury Shares figures stand at $4.7 million (Q4 2025), $3.8 million (Q4 2024), and $3.2 million (Q4 2023).